BACKGROUND: Laparoscopic Splenectomy (LS) is considered the treatment of choice for benign hematologic diseases of the spleen. However, the role of LS in malignancies is still controversial. Technical difficulties, hemorrhagic risk, the need of pathological characterisation of malignant disease, may be considered contraindications to LS in malignancies. This study aims to verify the efficacy and feasibility of LS for hematologic malignancies. METHODS: 145 patients underwent LS for hematologic disease and were retrospectively shared in two groups: Group A (83 patients) patients with preoperative diagnosis of benign hematologic disease and Group B (62 patients) with malignancies. Bipolar spleen diameter, mean operative time, conversion rate and causes, complications and need of transfusion were evaluated. RESULTS: Median splenic diameter was greater in Group B than in Group A with a statistically significant difference (p<0.005), such as higher were the number of accessory mini-laparotomy (p<0.005) and conversion rate (p=0.024) in the group of patients with a diagnosis of malignancy. The mean operative time was 117.6 min. in group A and 148.1 min. in Group B (p<0.005). Besides, there were no significant differences relative to intra-operative and postoperative transfusions and the incidence of postoperative complications. No peri-operative mortality occurred. CONCLUSIONS: The analysis of our data highlights that LS for hematologic malignancies is effective and feasible even if it associated with higher conversion rate due to splenomegaly and difficult hilum dissection. Besides, no differences in the patient outcome were highlighted. LS may be considered a safe procedure in the treatment of haematological malignancies of the spleen.

Laparoscopic splenectomy in malignancies: is it safe and feasible? / Serra, F; Roli, Isabella; Campanelli, M; Cabry, F; Baschieri, F; Romano, F; Gelmini, R.. - In: MINERVA CHIRURGICA. - ISSN 0026-4733. - 74:5(2019), pp. 365-373. [10.23736/S0026-4733.19.07851-9]

Laparoscopic splenectomy in malignancies: is it safe and feasible?

Serra F;Roli, Isabella;Campanelli M;Cabry F;Gelmini R.
2019

Abstract

BACKGROUND: Laparoscopic Splenectomy (LS) is considered the treatment of choice for benign hematologic diseases of the spleen. However, the role of LS in malignancies is still controversial. Technical difficulties, hemorrhagic risk, the need of pathological characterisation of malignant disease, may be considered contraindications to LS in malignancies. This study aims to verify the efficacy and feasibility of LS for hematologic malignancies. METHODS: 145 patients underwent LS for hematologic disease and were retrospectively shared in two groups: Group A (83 patients) patients with preoperative diagnosis of benign hematologic disease and Group B (62 patients) with malignancies. Bipolar spleen diameter, mean operative time, conversion rate and causes, complications and need of transfusion were evaluated. RESULTS: Median splenic diameter was greater in Group B than in Group A with a statistically significant difference (p<0.005), such as higher were the number of accessory mini-laparotomy (p<0.005) and conversion rate (p=0.024) in the group of patients with a diagnosis of malignancy. The mean operative time was 117.6 min. in group A and 148.1 min. in Group B (p<0.005). Besides, there were no significant differences relative to intra-operative and postoperative transfusions and the incidence of postoperative complications. No peri-operative mortality occurred. CONCLUSIONS: The analysis of our data highlights that LS for hematologic malignancies is effective and feasible even if it associated with higher conversion rate due to splenomegaly and difficult hilum dissection. Besides, no differences in the patient outcome were highlighted. LS may be considered a safe procedure in the treatment of haematological malignancies of the spleen.
2019
2-mag-2019
74
5
365
373
Laparoscopic splenectomy in malignancies: is it safe and feasible? / Serra, F; Roli, Isabella; Campanelli, M; Cabry, F; Baschieri, F; Romano, F; Gelmini, R.. - In: MINERVA CHIRURGICA. - ISSN 0026-4733. - 74:5(2019), pp. 365-373. [10.23736/S0026-4733.19.07851-9]
Serra, F; Roli, Isabella; Campanelli, M; Cabry, F; Baschieri, F; Romano, F; Gelmini, R.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1186859
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact